U.S. federal trademark · Serial No. 98774561
Design, development, and implementation of software for predicting asset values, determine pricing, evidence-generation, contracting by utilizing a pricing and generalized value module and commercial due diligence module, building recommendations based on clinical evidence of benefit and risk, expediting value assessment and providing qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting. Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses, Software as a service (SAAS) featuring software for predicting business asset values, determining pricing, evidence generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module.
Computer software platforms, downloadable, for predicting asset values, determine pricing, evidence-generation, contracting by utilizing a pricing and generalized value module and commercial due diligence module, building recommendations based on clinical evidence of benefit and risk, expediting value assessment and providing qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting, forecasting the empirical distribution of real-world clinical effectiveness for pipeline candidates or newly launched medicines to support commercial decision making and/or customer engagement.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.